William Rastetter has become non-executive chairman of Illumina’s board of directors, while current board chair John Stuelpnagel has been appointed to the new position of chief operating officer, Illumina announced last week. Rastetter will continue to serve as full-time executive chairman of Biogen Idec. He was the CEO of Biogen from 1986 to 2003, when it merged with Idec Pharamaceuticals. Stuelpnagel is a founding member of Illumina, and once served as its CEO and chief financial officer. He also was a venture capital associate for both CW Group and Catalyst Partners.
Samraat Raha, former vice president of GE Healthcare’s CodeLink microarray product line, has joined Agilent Technologies’ Life Science and Chemical Analysis (LSCA) business unit as vice president of field operations for the Americas. He manages the sales and marketing operations for the Americas, including all LSCA markets. Raha joined Amersham before the company was acquired by General Electric. He worked there for almost two years before joining Agilent. Previously, he was chief business officer for EraGen of Madison, Wis., and prior to that, he was vice president of discovery services and bioreagents for Incyte Genomics.
Tina Nova has been appointed to the board of directors of Cyntellect, the company announced last week. Nova is currently president, CEO, and co-founder of Genoptix. Nova also co-founded Nanogen, where she served as both its chief operating officer and president. She has served as COO of Selective Genetics, and held director-level positions with Ligand Pharmaceuticals.
Melissa Cline has left her post as a bioinformatics scientist at Affymetrix to join Benno Schwikowski’s lab at the Pasteur Institute in Paris. Cline told BioArray News’ sister publication BioInform that the primary focus of her work will be further development of Pasteur’s Cytoscape software platform for visualizing and modeling biological pathways and molecular interactions.